1. Home
  2. ANGH vs LTRN Comparison

ANGH vs LTRN Comparison

Compare ANGH & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anghami Inc.

ANGH

Anghami Inc.

N/A

Current Price

$3.35

Market Cap

33.8M

ML Signal

N/A

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

HOLD

Current Price

$0.62

Market Cap

10.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANGH
LTRN
Founded
2012
2013
Country
United Arab Emirates
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.8M
10.0M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
ANGH
LTRN
Price
$3.35
$0.62
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $17.50
AVG Volume (30 Days)
13.7K
★ 296.9K
Earning Date
04-30-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 18.65
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$251.30
N/A
Revenue Next Year
$26.67
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.25
$0.60
52 Week High
$7.89
$4.34

Technical Indicators

Market Signals
Indicator
ANGH
LTRN
Relative Strength Index (RSI) 48.99 19.81
Support Level $3.11 N/A
Resistance Level $3.89 $1.96
Average True Range (ATR) 0.23 0.09
MACD -0.03 0.03
Stochastic Oscillator 50.34 6.08

Price Performance

Historical Comparison
ANGH
LTRN

About ANGH Anghami Inc.

Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. The Group's three reportable segments: Revenue from subscriptions, Revenue from advertisement, and Revenue from live events. It generates the majority of its revenue from subscriptions segment, which is comes from subscription fees. The advertisement revenue segment generated through the sale of advertising across the Group's content. Revenues from live events are generated from the sale of tickets, food and beverage & sponsorship. It derives maximum revenue from KSA.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Share on Social Networks: